NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Henan Sahe Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+10 more ↓
76%
Finnrick rating
#237 of 419 Retatrutide vendors
31 of 41 classifiable tests passed
customers 4.8★ (45)
methodology · Purity focus
Finnrick analysis · Retatrutide

Henan Sahe Peptide's Retatrutide rating is held down by recurring purity misses and four identity failures. Late-September clean results showed a rebound, but the Oct 9 identity fail keeps the trajectory volatile.

methodology →
vendor intelligence report
Vendor Intelligence Report: Henan Sahe Peptide

Corporate records and web infrastructure tie Sahe to a migrating SH brand cluster with a dead storefront, a Dubai retail layer and a legal name rendered through CSS. COA trails and search-network artifacts point to a white-label supply role, while attribution remains unresolved.

37 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.47
80%
21
2
GHK-Cu
$0.07
79%
11
3
Retatrutideselected
$0.81
76%
42
4
Semaglutide
$0.45
65%
2
5
Ipamorelin
$0.82
60%
2
6
KLOW
$0.35
58%
3
7
Cagrilintide
$2.44
50%
3
9
CJC-IPA
-
44%
3
10
TB-500
$19.20
38%
3
11
MOTS-c
$1.20
34%
6
12
BPC-157
-
-
0
14
Glutathione
$0.01
-
0
15
KPV
$0.71
-
0
16
LL-37
-
-
0
17
PT-141
$6.90
-
0
18
SS-31
$2.55
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%30 Sep 2025: 74%5 Oct 2025: 77%5 Oct 2025: 78%7 Oct 2025: 80%18 Nov 2025: 75%18 Nov 2025: 72%15 Jan 2026: 69%29 Jan 2026: 71%16 Feb 2026: 73%20 Feb 2026: 69%26 Feb 2026: 70%2 Mar 2026: 72%19 Mar 2026: 73%13 Apr 2026: 75%15 Apr 2026: 76%23 Apr 2026: 77%30 Apr 2026: 78%6 May 2026: 79%20 May 2026: 80%20 May 2026: 80%4 Jun 2026: 77%12 Jun 2026: 78%12 Jun 2026: 79%17 Jun 2026: 80%22 Jun 2026: 77%24 Jun 2026: 78%24 Jun 2026: 78%26 Jun 2026: 79%26 Jun 2026: 77%1 Jul 2026: 77%13 Jul 2026: 78%17 Jul 2026: 76%20 Jul 2026: 76%4 Aug 2026: 77%9 Aug 2026: 75%23 Sep 2026: 75%23 Sep 2026: 76%24 Sep 2026: 77%30 Sep 2026: 77%6 Oct 2026: 78%9 Oct 2026: 76%15 Nov 2026: current 76%74%69%76%Sep 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Henan Sahe Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Henan Sahe Peptide Retatrutide test history
COA-backed lab tests
1-10 of 42

About Henan Sahe Peptide test results from Finnrick

Henan Sahe Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 99 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Henan Sahe Peptide peptides in this dataset are Cagrilintide (3 tests), CJC-IPA (3 tests) and GHK-Cu (11 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 99 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from Henan Sahe Peptide? Mail in a sample (US only) and let us test it.

Test my supply